Objective: To identify markers associated with in-hospital death in patients with coronavirus disease 2019 (COVID-19)-associated pneumonia.
Patients and methods: A retrospective cohort study was conducted of 140 patients with moderate to critical COVID-19-associated pneumonia requiring oxygen supplementation admitted to the hospital from January 28, 2020, through February 28, 2020, and followed up through March 13, 2020, in Union Hospital, Wuhan, China. Oxygen saturation (SpO2) and other measures were tested as predictors of in-hospital mortality in survival analysis.
Results: Of 140 patients with COVID-19-associated pneumonia, 72 (51.4%) were men, with a median age of 60 years. Patients with SpO2 values of 90% or less were older and were more likely to be men, to have hypertension, and to present with dyspnea than those with SpO2 values greater than 90%. Overall, 36 patients (25.7%) died during hospitalization after median 14-day follow-up. Higher SpO2 levels after oxygen supplementation were associated with reduced mortality independently of age and sex (hazard ratio per 1-U SpO2, 0.93; 95% CI, 0.91 to 0.95; P<.001). The SpO2 cutoff value of 90.5% yielded 84.6% sensitivity and 97.2% specificity for prediction of survival. Dyspnea was also independently associated with death in multivariable analysis (hazard ratio, 2.60; 95% CI, 1.24 to 5.43; P=.01).
Conclusion: In this cohort of patients with COVID-19, hypoxemia was independently associated with in-hospital mortality. These results may help guide the clinical management of patients with severe COVID-19, particularly in settings requiring strategic allocation of limited critical care resources.
Trial registration: Chictr.org.cn Identifier: ChiCTR2000030852.
Copyright © 2020. Published by Elsevier Inc.
Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China.Clin Infect Dis. 2020 May 3:ciaa538. doi: 10.1093/cid/ciaa538. Online ahead of print. Clin Infect Dis. 2020. PMID: 32361723 Free PMC article.
Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China.Clin Infect Dis. 2020 Mar 16:ciaa272. doi: 10.1093/cid/ciaa272. Online ahead of print. Clin Infect Dis. 2020. PMID: 32176772 Free PMC article.
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.JAMA Intern Med. 2020 Mar 13:e200994. doi: 10.1001/jamainternmed.2020.0994. Online ahead of print. JAMA Intern Med. 2020. PMID: 32167524 Free PMC article.
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.JAMA Cardiol. 2020 Mar 25:e200950. doi: 10.1001/jamacardio.2020.0950. Online ahead of print. JAMA Cardiol. 2020. PMID: 32211816 Free PMC article.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.Diabetes Care. 2020 May 14:dc200598. doi: 10.2337/dc20-0598. Online ahead of print. Diabetes Care. 2020. PMID: 32409504